Skip to content

OrthoPediatrics KIDS Enterprise value

Enterprise value at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Stryker logo
StrykerSYK
$137.35B-12.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$577.67M-23.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$24.74B-12.7%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
Alphatec Holdings logo
Alphatec HoldingsATEC
$2.11B+11.7%

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0.0×
Current ratio5.2×-1.0×

Where this comes from

Calculated from OrthoPediatrics’s reported figures.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's enterprise value?
OrthoPediatrics (KIDS) reported enterprise value of $392.34M in Q1 2026.
How has OrthoPediatrics's enterprise value changed year-over-year?
OrthoPediatrics's enterprise value decreased by 30.5% year-over-year, from $564.21M to $392.34M.
What is the long-term trend for OrthoPediatrics's enterprise value?
Over 5 years (2020 to 2025), OrthoPediatrics's enterprise value has grown at a -10.9% compound annual growth rate (CAGR), from $782.78M to $440.47M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.